# Polythiophenes with Cationic Phosphonium Groups as Vectors for Imaging, siRNA Delivery, and Photodynamic Therapy

Laure Lichon, Clément Kotras, Bauyrzhan Myrzakhmetov, Philippe Arnoux, Morgane Daurat, Christophe Nguyen, Denis Durand, Karim Bouchmella, Lamiaa Mohamed Ahmed Ali, Jean-Olivier Durand, et al.

► To cite this version:

Laure Lichon, Clément Kotras, Bauyrzhan Myrzakhmetov, Philippe Arnoux, Morgane Daurat, et al. Polythiophenes with Cationic Phosphonium Groups as Vectors for Imaging, siRNA Delivery, and Photodynamic Therapy. Nanomaterials, 2020, 10 (8), pp.1432. 10.3390/nano10081432. hal-02941551

HAL Id: hal-02941551

https://hal.umontpellier.fr/hal-02941551

Submitted on 27 May 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Article

# Polythiophenes with Cationic Phosphonium Groups as Vectors for Imaging, siRNA Delivery, and Photodynamic Therapy

Laure Lichon¹, Clément Kotras²,³, Bauyrzhan Myrzakhmetov⁴, Philippe Arnoux⁴✉, Morgane Daurat⁵, Christophe Nguyen¹, Denis Durand¹, Karim Bouchmella³, Lamiaa Mohamed Ahmed Ali ¹,⁶✉, Jean-Olivier Durand³✉, Sébastien Richeter³, Céline Frochot⁴✉, Magali Gary-Bobo ¹,*, Mathieu Surin² and Sébastien Clément ³,*,✉

¹ IBMM, University of Montpellier, CNRS, ENSCM, 34093 Montpellier, France; laure.lichon@umontpellier.fr (L.L.); christophe.nguyen@umontpellier.fr (C.N.); denis.durand@umontpellier.fr (D.D.); lamiaa.ali@umontpellier.fr (L.M.A.A.)

² Center of Innovation and Research in Materials and Polymers (CIRMAP), University of Mons—UMONS, 20 Place du Parc, 7000 Mons, Belgium; clement.kotras@umons.ac.be (C.K.); mathieu.surin@umons.ac.be (M.S.)

³ ICGM, University of Montpellier, CNRS, ENSCM, CC1701, Place Eugène Bataillon, 34095 Montpellier, France; karim.bouchmella@umontpellier.fr (K.B.); jean-olivier.durand@umontpellier.fr (J.-O.D.); sebastien.richeter@umontpellier.fr (S.R.)

⁴ Laboratoire Réactions et Génie des Procédés (LRGP), UMR 7274, Université de Lorraine, CNRS, 54000 Nancy, France; Bauyrzhan.myrzakhmetov@univ-lorraine.fr (B.M.); Philippe.Arnoux@univ-lorraine.fr (P.A.); celine.frochot@univ-lorraine.fr (C.F.)

⁵ NanoMedSyn, 15 Avenue Charles Flahault, 34093 Montpellier, France; morgane.daurat@umontpellier.fr

⁶ Department of Biochemistry, Medical Research Institute, University of Alexandria, Alexandria 21561, Egypt

* Correspondence: magali.gary-bobo@inserm.fr (M.G.-B.); sebastien.clement1@umontpellier.fr (S.C.); Tel.: +33(0)-4-11-75-96-17 (M.G.-B.); +33(0)-4-67-16-14-39-71 (S.C.)

<figure><img src="image_3.png" /></figure>

check for
updates

Received: 30 June 2020; Accepted: 16 July 2020; Published: 22 July 2020

**Abstract:** In this work, we exploit the versatile function of cationic phosphonium-conjugated polythiophenes to develop multifunctional platforms for imaging and combined therapy (siRNA delivery and photodynamic therapy). The photophysical properties (absorption, emission and light-induced generation of singlet oxygen) of these cationic polythiophenes were found to be sensitive to molecular weight. Upon light irradiation, low molecular weight cationic polythiophenes were able to light-sensitize surrounding oxygen into reactive oxygen species (ROS) while the highest were not due to its aggregation in aqueous media. These polymers are also fluorescent, allowing one to visualize their intracellular location through confocal microscopy. The most promising polymers were then used as vectors for siRNA delivery. Due to their cationic and amphipathic features, these polymers were found to effectively self-assemble with siRNA targeting the luciferase gene and deliver it in MDA-MB-231 cancer cells expressing luciferase, leading to 30–50% of the gene-silencing effect. In parallel, the photodynamic therapy (PDT) activity of these cationic polymers was restored after siRNA delivery, demonstrating their potential for combined PDT and gene therapy.

**Keywords:** combined therapy; conjugated polyelectrolyte; imaging; photodynamic therapy; polythiophenes; siRNA delivery

## 1. Introduction

Cancer is a multifaceted and complex disease, which remains one of the main causes of death, forcing researchers to continuously develop new anticancer treatments with high efficiency
and specificity [1,2]. Most current types of cancer treatments based on chemotherapy and radiotherapy, although beneficial, present multiple side effects including toxicity, non-targeted damage of tissues, neurotoxicity or multidrug resistance [3,4]. Today, photodynamic therapy (PDT) is considered as an interesting alternative to these treatments. Indeed, this therapeutic approach is highly localized and minimally invasive [5]. PDT uses photosensitizers (PSs), which generate reactive oxygen species (ROS) from molecular oxygen under light illumination and thus can directly lead to the cancer cell death mainly through apoptosis or necrosis, and indirectly by inducing tumor vasculature shutdown and recruitment of immune mediators [6]. However, this operational dependence in oxygen in a tumor microenvironment can lead to tumor hypoxia, trigger the signaling cascade mediated by hypoxia inducible factor (HIF) and release pro-angiogenic growth factors, which are ultimately responsible for cancer cell survival or tumor regrowth [7]. To enhance its therapeutic efficiency, the development of oxygen-independent therapeutic approaches is required to collaborate with PDT [8–13].

In this respect, gene silencing using small interfering RNA (siRNA) to block gene expression in a highly sequence-specific manner represents a valuable therapeutic approach to combine with PDT [14,15]. Notably, the combination of PDT with silencing critical cancer-associated proteins using siRNA has led to increased PDT efficacy and a remarkable antiproliferative effect [16–20]. To combine PDT with gene delivery, cationic amphiphilic systems based on a hydrophobic PS embedded into inorganic nanoparticles [14,21–23] or cationic micelles [13,15,24] are mostly studied. However, these nanosystems can suffer from several drawbacks, such as an undesirable separation between a PS and a carrier avoiding a synergistic effect or the possible aggregation of the PS leading to a reduced generation of ROS [25,26]. For these reasons, alternative multifunctional systems that induce siRNA release and cooperate with robust PDT are still required.

In this context, conjugated polyelectrolytes (CPEs), i.e., polymers with a π-conjugated backbone and bearing ionic flexible side chains [27], have emerged as promising systems for such purpose. Indeed, the presence of the ionic side groups enables their dissolution in aqueous media and their interaction with biologically relevant targets such as DNA [28–33]. Besides, their conjugated backbone determines their intrinsic optical properties, such as absorption, fluorescence, and light-harvesting ability, enabling their use in the development of chemo- and biosensors, as well as in bioimaging applications [34–37]. Exploiting all these versatile features, CPEs were exploited as imaging systems and gene delivery vehicles exhibiting low toxicity and good photostability, together with high delivery and transfection efficiencies [38–42]. In particular, their ability to generate ROS under light illumination has been proved to be a tool of choice in the release of nucleic acids from the endolysosomal compartment to the cytoplasm by destabilizing their membranes and fostering the lysosomal escape [40,42–44]. Recently, Fan et al. even reported the combination of PDT with siRNA release in photo-induced charge-variable CPE brushes that encapsulate up-conversion nanoparticles leading to a cumulative antitumor effect between these two therapeutic approaches [45].

Herein, the therapeutic potential of cationic polythiophene-based CPEs as a multifunctional platform in order to combine PDT with siRNA delivery is described. Cationic polythiophenes possess suitable features for this purpose, such as an important affinity for nucleic acids as well as the ability to photosensitize oxygen [43,44,46–49]. However, water-soluble polythiophenes are generally prepared through a step-growth polymerization method, the resulting structural defects of which affect both the optical properties (absorption, fluorescence) and DNA binding/condensing ability [43,47–49]. The availability of a versatile synthetic strategy, e.g., the Kumada Catalyst-Transfer Condensative Polymerization (KCTCP) enables to overcome such drawbacks through a high degree of control over the final structure and molecular weight [50,51]. As such, a detailed investigation of structure–property relationships, notably the effect of molecular weight, an important parameter when considering gene delivery applications influencing both cytotoxicity, complexation and transfection efficiency, can be performed [52–54]. In this work, a series of phosphonium-based conjugated polythiophenes with different molecular weights (11.5 kDa to 53 kDa) was synthesized. The choice of phosphonium head group was motivated by the promising potential of phosphonium-containing polymers compared
to their corresponding ammonium analogues in gene delivery applications [55]. Indeed, the more localized positive charge distribution at the P atom is supposed to be the origin of the higher nucleic acid binding ability [56]. Studies also revealed that phosphonium-containing polymer vectors result in lower cell toxicity and increased transfection efficiency with respect to their ammonium analogues [56,57]. The photophysical properties (absorption, fluorescence emission, light-induced generation of singlet oxygen) of the synthesized regioregular cationic polythiophenes were found to be dependent on the molecular weight. Their fluorescent properties were exploited for imaging to determine their intracellular location. Finally, their potential to deliver genetic material and act as a PS in a cooperative manner was examined.

## 2. Materials and Methods

### 2.1. *Polymer Synthesis and Characterisation*

Poly(3-(6'-bromohexylthiophene)) (*P3HT-Br*) precursors were synthesized according to reported procedures [31,58]. The polymer characteristics (number averaged ($M_n$) and weight-averaged ($M_w$) molecular weights and the molecular weight distribution (D)) of *P3HT-Br1* were estimated by size exclusion chromatography (SEC). An Agilent liquid chromatograph integrating an Agilent degasser (Diegem, Belgium), an isocratic HPLC pump with chloroform ($CHCl_3$) as an eluent at a flow rate of 1 mL min$^{-1}$, an Agilent autosampler (loop volume = 100 µL) with a polymer concentration in a solution of 2 mg mL$^{-1}$, an Agilent-DRI refractive index detector (Diegem, Belgium), and three columns (a PL gel 5 µm guard column and two PL gels Mixed-B 5 µm columns (linear columns for separation of $M_w$ of polystyrene (PS) ranging from 200 to $4 \times 10^5$ g mol$^{-1}$)) was used. For the two other poly(3-6'-bromohexyl)thiophene) precursors, SEC analyses were performed in THF at 35 °C. A Polymer Laboratories liquid chromatograph was used. This chromatograph integrates a PL-DG802 degasser, an isocratic HPLC pump LC 1120 (flow rate = 1 mL min$^{-1}$), a Marathon autosampler (loop volume = 200 mL) with a polymer concentration in a solution of 1 mg mL$^{-1}$, a PL-DRI refractive index detector, and three columns: a PL gel 10 mm guard column and two PL gels Mixed-B 10 mm columns (linear columns for the separation of $M_w$ PS standards ranging from 500 to $10^6$ Da). Calibration was performed in both cases with polystyrene standards.

### 2.2. *UV-Visible Absorption and Emission Properties*

Absorption spectra were measured on a UV-3600 UV-visible double beam spectrophotometer using Software UVProbe 2.33 (SHIMADZU, MARNE LA VALLEE, France). Fluorescence spectra were measured on a Fluorolog FL3-222 spectrofluorimeter using Software DataMax 2.20 (HORIBA Jobin Yvon, Longjumeau, France). The spectrofluorimeter is fitted with a 450 W Xenon lamp, a thermostated cell compartment (25 °C), a UV-visible photomultiplier R928 (HAMAMATSU Photonics, Hamamatsu, Japan) and an InGaAs infrared detector (DSS-16A020L Electro-Optical System Inc., Phoenixville, PA, USA). Excitation and emission beams are diffracted by double-ruled grating SPEX monochromators with the following features: 1200 grooves/mm blazed at 330 nm for excitation and 1200 grooves/mm blazed at 500 nm for emission, respectively. The detection of singlet oxygen emission was performed by using a double-ruled grating SPEX monochromator (600 grooves/mm blazed at 1 µm) and a long-wave pass (780 nm). All spectra were recorded by using 4 faces quartz cells. All the emission spectra (fluorescence and singlet oxygen luminescence) were recorded at the same absorbance (less than 0.2 at the excitation wavelength) by exploiting the lamp and photomultiplier corrections.

Fluorescence lifetime measurements were performed using a pulsed laser diode emitting at 407 nm (LDH-P-C-400M, FWHM < 70 ps, 1 MHz) coupled with a driver PDL 800-D (PicoQuant GmbH, BERLIN, Germany) for excitation and an avalanche photodiode SPCM-AQR-15 (EG & G, VAUDREUIL, Canada) coupled with a 550 nm long-wave pass filter as a detection system for excitation. A PicoHarp 300 module with a 4-channel router PHR-800 (both PicoQuant GmbH, Berlin, Germany) was used for acquisition. The single photon counting method was employed to record the fluorescence decays.
The collection of data was performed up to 1000 counts. The data were accumulated in the maximum channel and analyzed using Time Correlated Single Photon Counting (TCSPC) software Fluofit 4.2 (PicoQuant GmbH, Berlin, Germany) based on iterative reconvolution using a Levensberg-Marquandt algorithm, which enables one to obtain multi-exponential profiles (mainly one or two exponentials in our cases).

## 2.3. Singlet Oxygen Measurements

Singlet oxygen lifetimes have been measured exploiting a TEMPRO-01 spectrophotometer (HORIBA Jobin Yvon, Longjumeau, France) equipped with a pulsed diode excitation source SpectraLED-415 ($\lambda_{em}$ = 415 nm), a cell compartment, a Seya-Namioka-type emission monochromator (600–2000 nm) and a detection system (H10330-45 near-infrared photomultiplier tube with thermoelectric cooler (HAMAMATSU Photonics, Hamamatsuç, Japan). A single photon counting controller FluoroHub-B and the softwares DataStation 2.5.11 and DAS6 6.6 (HORIBA Jobin Yvon, Longjumeau, France) were used to monitor the system.

## 2.4. Dynamic Light Scattering (DLS) and Zeta Potential

Hydrodynamic diameter and zeta potential were estimated using a Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, UK). The cationic polythiophenes (5 µM) and cationic polythiophenes/siRNA polyplexes at a P+/P- ratio of 100 (5 µM) were prepared in water. The measurements were then performed after 30 min incubation at 37 °C to guarantee the complexation of siRNA. Particle size measurements were carried out with transparent ZEN0040 disposable micro-cuvette (40 µL) at 25 °C. Zeta potential measurements were performed at 25 °C and were carried out in DTS 1070 zeta potential cells made with 18 runs for each.

## 2.5. Cell Culture Conditions

Human breast adenocarcinoma MDA-MB-231, the standard cell line or this expressing luciferase and red fluorescent protein (MDA-MB-231 Luc RFP) were purchased from ATCC and AMSBIO (Abingdon, UK), respectively. Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM), incorporating 10% fetal bovine serum and antibiotic (0.05 mg mL⁻¹ gentamycin). The cell growth was performed in humidified atmosphere at 37 °C under 5% CO₂.

## 2.6. In Vitro Cytotoxicity Assay

The in vitro cytotoxicity analyses were performed by using MDA-MB-231 cells seeded into 96-well culture plates, 2000 cells per well in 200 µL of culture medium, and allowing them to grow for 24 h. The cells were then treated with different concentrations of phosphonium-based polythiophene conjugated polyelectrolytes, and, after 3 days, a colorimetric assay of living cells (MTT, (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, assay) was performed, as previously described [59].

## 2.7. In Vitro Phototoxicity Assay

In vitro phototoxicity assays were performed with MDA-MB-231 cells seeded into 96-well plates at a concentration of ~2 × 10³ cells/well in 100 µL of culture medium and allowed to grow for 24 h. The cells were then incubated for 24 h in the presence or absence of polymer (5 µM in water). After incubation with polymers, cells were submitted, or not, to light excitation ($\lambda$ = 450 nm, 1.45 J cm⁻²) for 5 min. A total of 48 h after irradiation, the cytotoxicity or phototoxicity of the polymers were evaluated using an MTT assay. Briefly, the incubation of cells was performed in the presence of MTT (0.5 mg mL⁻¹) during 4 h to determine mitochondrial enzyme activity. Then, the cell medium was aspirated and the MTT precipitates were dissolved in an ethanol/DMSO (1:1) solution (150 µL) and a reading of the absorbance at 540 nm was performed.
## 2.8. Confocal Fluorescent Imaging on Living Cells

Confocal fluorescent imaging was performed on MDA-MB-231 cells seeded onto glass bottom dishes (World Precision Instrument, Stevenage, UK) at a concentration of 10⁶ cells cm⁻². One day after seeding, cells were incubated in the presence or absence of **PTH1**, **PTH2** and **PTH3** (10 µM) for 24 h. The incubation of cells with Hoechst 33,342 (5 µg mL⁻¹, Invitrogen) was performed for nuclear staining for 15 min and cells were washed 3 times with culture medium. Fluorescence pictures were recorded on confocal microscope (LSM 780 live, Carl Zeiss Microscope) under a 450 nm wavelength excitation for polythiophenes detection and a 760 nm wavelength for nuclei imaging. A high magnification (63×/1.4 OIL DIC Plan-Apo) was used for all images.

## 2.9. Gel Electrophoresis with siRNA

A total of 5 µL of a 20 µM siRNA, mixed with the appropriate amounts of polythiophenes (in order to reach the desired P⁺/P⁻ ratio) in RNase free water (final volume: 20 µL) was used to perform gel retardation assays with siRNA and 4 µL of Blue 6X loading dye (Fisher Scientific, Hampton, NH, USA) was then added. These samples were submitted to an electrophoresis performed with a 2% wt/vol agarose gel in TBE (90 mM Tris-borate/2 mM EDTA, pH 8.2) at 50 V for 1 h. The standard was a 100 bp DNA ladder (Sigma-Aldrich, Saint-Quentin-Fallavier, France). To visualize siRNA, a GelRed nucleic acid gel stain (Interchim, Montluçon, France) was used allowing to detect siRNA through an ultraviolet transilluminator (Infinity Gel documentation Imaging, Vilber Lourmat, Paris, France).

## 2.10. In Vitro Combined PDT and siRNA Delivery

MDA-MB-231 Luc RFP cells derived from MDA-MB-231 human breast cancer cells by the stable transfection of firefly luciferase gene and RFP for red coloration and easy detection were used. They were seeded in a multiwell plate (96 well white opaque tissue culture plates) at 2 × 10³ cells cm⁻² in 100 µL culture medium. Eight hours after seeding, the cells were incubated with or without 5 µM **PTH2**/siRNA and **PTH3**/siRNA polyplexes at a P⁺/P⁻ ratio of 100 during the allocated 24 h. The quantities of siRNA used for **PTH2** and **PTH3** complexation were 132 and 81 µM, respectively. Cells were irradiated for 5 min using a standard fluorescent microscope (Leica DM IRB) with a mercury lamp at 450 nm, magnification x4. Next day, cells were irradiated for a second time with the same process. The day after, to quantify either the cell death or the transfection efficiency of a 21-mer siRNA targeting the expression of luciferase inside MDA-MB 231 Luc RFP cells, cells were submitted to an MTT assay and to luciferase activity assay, respectively. The siRNA targeting sequence (sense: AACUUACGCUGAGUACUUCGA and anti-sense UCGAAGUACUCAGCGUAAGUU) for luciferase was purchased from Eurogentec (Serring, Belgium). The addition into a culture medium of luciferin (10⁻³ M, Promega, Charbonnières-les-Bains, France) was used to determine the expression of luciferase. A total of 10 min after, a plate reader CLARIOstar® High-Performance Monochromator Multimode Microplate Reader (BMG Labtech, Ortenberg, Germany) was used to measure living cell luminescence. The cytotoxicity or phototoxicity of polymers were evaluated by MTT assay.

## 2.11. Statistical Studies

Statistical analyses were carried out using student t-test, to compare paired groups of data. A p-value of <0.05 was considered to be statistically significant.

# 3. Results and Discussion

## 3.1. Polymer Synthesis

The phosphonium-based polythiophene conjugated polyelectrolytes were synthesized according to our previous reported procedures [31,58]. Briefly, poly(3-(6'-bromohexyl)thiophene) precursors (**P3HT-Br**) were first synthesized by KCTCP (Scheme 1), which enables the preparation of
polythiophenes with a high degree of control over the final structure and the molecular weight [50,58,60]. Indeed, due to the living chain-growth polymerization mechanism, a control on the molecular weight of the polymer can be achieved by carefully tuning the feed ratio of monomer to the nickel catalyst [50,60]. Using this method, three different well-defined polymer precursors were synthesized in view of evaluating the effect of polythiophene molecular weight on the PDT effect and gene delivery properties (Table 1). These precursors were then converted in 75–80% yield into the corresponding phosphonium-based polythiophene CPEs by reaction with trimethylphosphine (Scheme 1) [31]. The polyelectrolyte nature of these CPEs prevents direct molecular weight determination using size exclusion chromatography (SEC). Consequently, the molecular weights of these CPEs were estimated from the number of units calculated from the **P3HT-Br** precursors and the molar mass of the phosphonium repeating unit (321 g·mol⁻<fnref n="1" />) leading to M_n = 53 kDa (**PTH1**), M_n = 19 kDa (**PTH2**) and M_n = 11.5 kDa (**PTH3**).

<figure><img src="image_4.png" /><figcaption>**Scheme 1.** Synthetic pathway towards phosphonium-based conjugated polyelectrolytes (CPEs) (PTH).</figcaption></figure>

<table><caption>**Table 1.** Characteristics of the synthesized **P3HT-Br** precursors.</caption><thead><tr><th>Name</th><th>Yield (%)</th><th>M<sub>n</sub> (g·mol<sup>-1</sup>) <sup>1</sup></th><th>Đ</th><th>DP <sup>2</sup></th></tr></thead><tbody><tr><td>P3HT-Br1</td><td>55</td><td>40,600</td><td>1.16</td><td>165</td></tr><tr><td>P3HT-Br2</td><td>72</td><td>14,500</td><td>1.28</td><td>59</td></tr><tr><td>P3HT-Br3</td><td>62</td><td>8,500</td><td>1.31</td><td>36</td></tr></tbody></table>

## 3.2. Optical Properties of the Phosphonium-Based Polythiophene CPEs

The UV-visible absorption and emission spectra of CPEs are depicted in Figure 1 and the corresponding data are summarized in Table 2.

<table><caption>**Table 2.** Optical characteristics of phosphonium-based polythiophene CPEs in water.</caption><thead><tr><th>Compound</th><th>λ<sub>abs max</sub> (nm)</th><th>λ<sub>em max</sub> (nm) <sup>1</sup></th><th>Φ<sub>F</sub> <sup>2</sup></th><th>τ<sub>F</sub> (ns)</th><th>Φ<sub>Δ</sub></th></tr></thead><tbody><tr><td>PTH1</td><td>495</td><td>624</td><td>0.01</td><td>0.5</td><td>&lt; 0.01</td></tr><tr><td>PTH2</td><td>464</td><td>605</td><td>0.07</td><td>0.7</td><td>0.13</td></tr><tr><td>PTH3</td><td>466</td><td>605</td><td>0.08</td><td>0.7</td><td>0.15</td></tr></tbody></table>

The UV-visible absorption spectra of these CPEs show a broad absorption band attributed to a π-π* transition [63]. The maxima absorption wavelengths (λ<sub>abs max</sub>) are observed at ~465 nm for **PTH2** and **PTH3**, while a red-shifted absorption is noticed (495 nm) for **PTH1**, indicating a significant extent of the π-conjugation. The emission spectra of these CPEs are also dependent on the molecular weight since a maxima emission wavelength of 605 nm is found for **PTH2** and **PTH3**, whereas, for **PTH1**, an emission broad band centered at ~620 nm is observed. These results suggest that the cationic polythiophene **PTH1** adopts a more ordered and planar conformation, which may be due to the polymer aggregation in water. Indeed, compared to other CPEs, **PTH1** exhibits a lower

<footnote n="1">¹ M_n determined by SEC in THF except for **P3HT-Br3**, which was performed in CHCl₃. ² Degree of polymerization calculated from M_n.</footnote>

<footnote n="1">¹ λ<sub>exc</sub> = 466 nm, ² measured using tris(bipyridine)ruthenium(II) chloride [Ru(bpy)₃]Cl₂ in water as a reference (Φ<sub>F</sub> = 0.042) [61], ³ measured using [Ru(bpy)₃]Cl₂ in D₂O as a reference (Φ<sub>Δ</sub> = 0.53) [62].</footnote>
solubility in water due to its much higher molecular weight. To gain insight into the aggregation
behaviour of these polymers, the fluorescence quantum yields of the three cationic polythiophenes
were measured using tris(bipyridine)ruthenium(II) chloride ([Ru(bpy)₃]Cl₂) in water as a reference
(ΦF = 0.042) [61]. As observed in Table 2, PTH2 and PTH3 exhibit similar fluorescence quantum yields
(7–8%) [48], whereas a strong decrease of the fluorescence quantum yields is noted for PTH1 (1%),
which is consistent with a significant aggregation in solution as a result of longer π-conjugated backbone
leading to increased interchain interactions and fluorescence self-quenching [64–66]. The increased
interchain contacts in solution for PTH1 in comparison with PTH2 and PTH3 are also evidenced
by the decrease in the singlet state emissive lifetime (0.5 ns vs. 0.7 ns) (Table 2 and Figure S1 in
the Supporting Information). These values of singlet state emissive lifetime are in good agreement with
those reported for poly(3-hexylthiophene) (P3HT) [67,68]. To evaluate the degree of aggregation of
these polymers, their size was then determined by Dynamic Light Scattering (DLS) leading to average
diameters of around 110 and 103 nm for PTH2 and PTH3, respectively, while, for PTH1, an average
diameter of around 527 nm is observed, confirming its aggregation in aqueous media (Figures S3–S5 in
the Supporting Information).

<figure><img src="image_5.png" /><figcaption>**Figure 1.** UV-vis. absorption spectra (solid line) and emission spectra ($\lambda_{exc}$ = 466 nm) (dotted line) of **PTH1** (0.37 µM), **PTH2** (0.68 µM) and **PTH3** (0.81 µM) in water.</figcaption></figure>

3.3. *Cytotoxicity, Imaging and Photodynamic Therapy Activity*

To demonstrate the in vitro biocompatibility of phosphonium-based polythiophene CPEs,
their cytotoxicity against MDA-MB-231 cells were estimated using the 3-[4,5-dimethylthiazol
-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) method, in which soluble MTT is converted into
formazan crystal by mitochondrial dehydrogenases, thus allowing one to measure the cell viability.
MDA-MB-231 cells were grown in 96-well culture plates and were then treated with **PTH1**, **PTH2**
and **PTH3** for 72 h. Figure 2A shows the effect of **PTH1**, **PTH2** and **PTH3** with concentrations ranging
from 0 to 500 µM (relative to repeating unit) on the viability of MDA-MB-231 cells. Although these
cationic polymers displayed in vitro toxicity from a concentration of 10 µM, the cell viability is still
larger than 70% at a concentration of 50 µM. These values are in good agreement with those previously
reported for other CPEs, such as cationic polyfluorenes [38] and poly(fluorene-co-thiophenes) [69].
From Figure 2A, the half inhibitory concentrations (IC50) values for these cationic polymers were also
determined leading respectively to IC50 > 100 µM for **PTH1** and **PTH2** and IC50 > 250 µM for **PTH3**.
Based on these results, cationic polymers were then used at a concentration of 5 µM for investigating
PDT and gene delivery applications.

Considering PDT applications, we first evaluated the ability of phosphonium-based polythiophene
CPEs to generate singlet oxygen (¹O₂) by monitoring photoluminescence of ¹O₂ at 1270 nm in aerated
$D_2O$ using $Ru(bpy)_3$ as a reference ($\Phi_\Delta = 0.53$) (Figure S2 in the Supporting Information) [62]. **PTH2** and **PTH3** showed relatively low $^1O_2$ luminescence quantum yield: $\Phi_\Delta = 0.12$ and $= 0.14$, respectively, while **PTH1** did not produce $^1O_2$ likely due to aggregation in solution resulting in increased interchain contacts and thus intermolecular charge transfer. Indeed, aggregation is known to lead to reduced ROS generation as previously observed for conventional PSs, such as porphyrins in aqueous media [70,71]. Then, we explored their cellular uptake by MDA-MB-231 cells. The internalization of **PTH1**, **PTH2** and **PTH3** in MDA-MB-231 cells was clearly visualized by fluorescence microscopy (Figure 2B) exploiting the fluorescence properties of phosphonium-based polythiophene CPEs. Indeed, the cationic charge of the phosphonium side groups of these polythiophene-based CPEs enables their binding to the negatively charged cell membrane and subsequently enhances their endocytosis by cells. As shown in Figure 2B, the orange fluorescence of **PTH1**, **PTH2** and **PTH3** indicated that they are mainly accumulated around the perinuclear region (located concurrently by Hoechst staining) [72]. Finally, the efficiency of CPEs as PSs towards MDA-MB-231 cells was evaluated in vitro under illumination.

<figure><img src="image_6.png" /><figcaption>**Figure 2.** (A) MDA-MB-231 cells were incubated with different concentrations of **PTH1**, **PTH2** and **PTH3** during 72 h. After treatment, cells were submitted to MTT assay to quantify the cell death. (B) MDA-MB-231 cells were incubated with or without **PTH1**, **PTH2** and **PTH3** during the allocated 24 h. The cells were incubated with Hoechst 15 min. They were imaged at 450 nm for polythiophenes and 760 nm for Hoechst using a confocal microscope. (C) MDA-MB-231 cells were incubated with **PTH1**, **PTH2** and **PTH3** during the allocated 24 h. The cells were irradiated for 5 min using a standard fluorescent microscope with a mercury lamp at 450 nm, magnification x4. Two days after irradiation, cells were submitted to MTT assay to quantify the cell death. \* Statistical significance (*p* < 0.05) of the irradiated condition versus the non-irradiated condition using Student's *t*-test.</figcaption></figure>

To this aim, MDA-MB-231 cells were incubated for 24 h with phosphonium-based polythiophene CPEs at 5 µM and then, submitted or not to monophotonic light excitation at 450 nm for 5 min. An MTT assay was performed two days after illumination to determine the cells viability. As indicated in Figure 2C, none of the cationic polymers showed significant cytotoxicity in the dark (between 4 and 12% cell death at 5 µM). After illumination at 450 nm for 5 min, **PTH2** and **PTH3** exhibits efficient phototoxicity, inducing around 60% cell death, whereas, in these conditions, no significant phototoxicity
is noted for **PTH1** due to its aggregation in aqueous media and thus its incapacity to generate ¹O₂ under illumination.

### 3.4. *In Vitro Combined PDT and siRNA Delivery*

The siRNA loading capability of **PTH1**, **PTH2** and **PTH3** was first studied. For this, an agarose-gel electrophoresis assay was performed to estimate the siRNA complexation efficiency of these cationic polythiophene according to the P⁺/P⁻ molar ratio between the positively charged phosphonium groups (P⁺) in the polymer and the negatively charged phosphodiester groups (P⁻). As shown in Figure 3A, as the P⁺/P⁻ ratio increases, the negative charges of siRNA were gradually neutralized and moved to a positive electrode (retardation effect), except for **PTH1**, in which, regardless of the used P⁺/P⁻ ratio, the siRNA migration was not inhibited. In the case of **PTH2** and **PTH3**, the migration of siRNA was inhibited at P⁺/P⁻ ratio of 100 and 50, respectively. Consequently, we decided to focus only on cationic polythiophenes **PTH2** and **PTH3** for the further combination of in vitro PDT and gene delivery since **PTH1** did not generate ¹O₂ and was not able to complex siRNA. A P⁺/P⁻ ratio of 100 was chosen for **PTH2** and **PTH3** for the further studies of the in vitro combined PDT and siRNA delivery. The size of the **PTH2/siRNA** and **PTH3/siRNA** polyplexes at a P⁺/P⁻ ratio of 100 was then determined by Dynamic Light Scattering leading to polyplexes with average diameters of around 82 and 92 nm, respectively (Figures S6 and S7 in the Supporting Information), a suitable size for facilitating endocytosis [73,74]. Furthermore, the positive zeta potential of **PTH2/siRNA** (ζ = 15 mV) and **PTH3/siRNA** (ζ = 20 mV) polyplexes at a P⁺/P⁻ ratio of 100 allows these polyplexes to interact with the negatively charged cell membrane favorizing their cellular uptake (Figure S5 and S6 in the Supporting Information) [40,75]. The in vitro PDT activity of **PTH2/siRNA** and **PTH3/siRNA** nanoparticles was first examined, exploiting the same conditions as described above. As shown in Figure 3B, siRNA complexation by cationic polythiophenes **PTH2** and **PTH3** led to the complete loss of the PDT activity of the polymers since no phototoxicity was noticed upon illumination, while, for polymers alone, around 60% cell death was observed. We speculate that this loss of PDT activity can be attributed to the formation of aggregates and thus fluorescence self-quenching and reduced ROS production [32,44].

<figure><img src="image_7.png" /><figcaption>**Figure 3.** (A) Gel electrophoresis analysis showing the complexation of siRNA by the polythiophenes under study. (B) MDA-MB-231 were incubated with **PTH2/siRNA** and **PTH3/siRNA** during the allocated 24 h. The cells were illuminated during 5 min using standard fluorescent microscope with a mercury lamp at 450 nm, magnification x4. Two days after illumination, cells were submitted to an MTT assay to quantify living cells.</figcaption></figure>

Finally, to evaluate the therapeutic potential of these polymers in PDT-siRNA combination therapy, we set up experiments using siRNA targeting the expression of luciferase gene in MDA-MB-231 Luc RFP cells. MDA-MB-231 Luc RFP cells were incubated for 24 h with **PTH2/siRNA** and **PTH3/siRNA**
polyplexes at a P⁺/P⁻ ratio of 100 at 5 µM and then submitted or not to one or two monophotonic light irradiations at 450 nm for 5 min, with the second light irradiations occuring 24 h after the first one. Figure 4 shows the obtained results for in vitro combined PDT and siRNA delivery exploiting PTH2/siRNA and PTH3/siRNA polyplexes in MDA-MB-231 Luc RFP cells. As observed previously in Figure 3B, the first light irradiation did not result in cell death, as confirmed in Figure 4A (red bars). However, it enables the delivery of siRNA targeting the luciferase gene inside MDA-MB 231 Luc RFP cells leading to 35% and 52% of luciferase gene silencing for PTH2 and PTH3, respectively (Figure 4B). The siRNA decomplexation is confirmed by the restoration of the PDT activity of PTH2/siRNA and PTH3/siRNA leading, respectively, to 44% and 49% of cell death after a second light irradiation (Figure 4A). This second light irradiation (green bars) also results in a significant improvement in the luciferase gene silencing, mainly for PTH2/siRNA leading to a 67% decrease in luminescence (Figure 4B). We can note that, for PTH3/siRNA, the effect on luminescence decrease is maximal after only one irradiation (48% at the first irradiation and 40% after 2 irradiations), suggesting that PTH3 can be more easily used for nucleic acid delivery. This light-triggered siRNA release will necesitate deeper investigation, and the understanding of the mechanism responsible for this effect will help us to develop highly potent polythiophenes for nucleic acid delivery under light stimulation. All in all, these results show the remarkable synergistic effect of using these cationic polymers both as a polymer vector for siRNA delivery and as a PS for PDT.

<figure><img src="image_8.png" /><figcaption>**Figure 4.** (A) MDA-MB-231 Luc RFP cells were incubated with PTH2/siRNA and PTH3/siRNA at a P⁺/P⁻ ratio of 100 during 24 h. The cells were irradiated for 5 min using a standard fluorescent microscope with a mercury lamp at 450 nm, magnification x4. After 24 h, the cells were irradiated a second time with the same process. The day after, the cells were submitted to an MTT assay to quantify the cell death. (B) Luciferase activity assay showing the transfection of a 21-mer siRNA targeting the expression of luciferase inside MDA-MB-231 Luc RFP cells. The experiments were carried out with PTH2/siRNA and PTH3/siRNA at a P⁺/P⁻ ratio of 100 without or after one or two irradiations (450 nm, 5 min). * Statistical significance (*p* < 0.05), of the irradiated condition versus non irradiated condition using Student's *t*-test.</figcaption></figure>

4. Conclusions

Phosphonium-based conjugated polythiophenes with different molecular weight (going from 11.5 kDa to 53 kDa) were prepared by KCTCP and used as multifunctional platforms to complex and deliver siRNA and to generate ROS species for PDT. Upon light irradiation, cationic polythiophenes PTH2 and PTH3 with lower molecular weight were able to light-sensitize surrounding oxygen into ROS, which could disturb the endosome-lysosome membrane and thus lead to an enhanced endosomal escape and more efficient gene delivery. In contrast, these polymers are also fluorescent, allowing for the imaging of intracellular location through confocal microscopy; thus, their good internalization
was confirmed. The most promising conjugated polyelectrolytes, **PTH2** and **PTH3**, were then used as carriers for siRNA delivery. Due to their cationic and amphipathic features, these polymers were found to effectively self-assemble with siRNA, deliver siRNA targeting the luciferase gene in MDA-MB-231 cancer cells expressing luciferase and lead to 35 and 52% of the gene silencing effect. In parallel, the photodynamic activity of these cationic polymers was restored after siRNA delivery, demonstrating their potential for combined PDT and gene therapy. Nevertheless, further investigation will be needed to determine the mechanism responsible for the light-triggered release of siRNA by these cationic polythiophenes. This study illustrates that multiple functions can be achieved by exploiting the features of conjugated polyelectrolytes and suitably tailoring their molecular structures (molecular weight, nature of the ionic group, etc.). To go further, modifying the polymer structure by introducing notably multiple cationic side groups per monomeric units will be necessary to improve their ability to bind and condense nucleic acid and their solubility in aqueous medium, which will thus positively impact their optical properties. In addition, two-photon excited photodynamic therapy and siRNA delivery experiments will be conducted in the future to extend the scope of this multifunctional platform.

**Supplementary Materials:** The following are available online at http://www.mdpi.com/2079-4991/10/8/1432/s1, Figure S1: Fluorescence decay of **PTH1** (0.37 µM), **PTH2** (0.68 µM) and **PTH3** (0.81 µM) in water in D₂O ($\lambda_{exc}$ = 407 nm), Figure S2: Singlet Oxygen emission spectra of **PTH1**, **PTH2** and **PTH3** in D₂O ($\lambda_{exc}$ = 466 nm), Figure S3: Particle Size distribution of **PTH1** in water (5 µM) at 25 °C, Figure S4: Particle Size distribution of **PTH2** in water (5 µM) at 25 °C, Figure S5: Particle Size distribution of **PTH3** in water (5 µM) at 25 °C, Figure S6: Particle size distribution (up) and zeta potential (down) of **PTH2**/siRNA polyplex in water (5 µM) at a P⁺/P⁻ ratio of 100 at 25 °C, Figure S7: Particle size distribution (up) and zeta potential (down) of **PTH3**/siRNA polyplex in water (5 µM) at a P⁺/P⁻ ratio of 100 at 25 °C. Figure S8: (A) MDA-MB-231 cells were incubated with **PTH1**, **PTH2**, **PTH3** during 72 h. Cells were irradiated using confocal microscope with a chameleon laser beam at 800 nm, magnification x10, during 3 x 1.57 seconds. Two days after irradiation, cells were submitted to a MTT assay to quantify the cell death. (B) MDA-MB-231 cells were incubated with or without **PTH1**, **PTH2**, **PTH3** during 24 h. Cells were incubated with Hoechst 15 min. They were imaged at 800 nm for polythiophenes and 760 nm for Hoechst using confocal microscope.

**Author Contributions:** Polymer synthesis, C.K. and S.R.; Optical properties, B.M., Singlet Oxygen Measurements, P.A. and C.F.; DLS and Zeta potential measurements, K.B.; formal analysis, J.-O.D.; PDT experiments, D.D.; confocal imaging M.D.; cytotoxicity study, siRNA delivery and combined PDT, L.L. and C.N.; statistical analysis, L.M.A.A.; supervision, M.S.; writing and project administration, M.G.-B. and S.C. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research was funded by Région Languedoc-Roussillon (Research Grant "Chercheur(se)s—d'Avenir 2015-005984) and the FEDER program (Fonds Européen de Développement Régional).

**Acknowledgments:** Research in Mons was supported by the University of Mons—UMONS and by the Fund for Scientific Research (F.R.S.-FNRS), under the grants MIS No. F.4532.16 (SHERPA) and EOS No. 30650939 (PRECISION). CK acknowledges UMONS for a Ph.D. grant. We acknowledge the imaging facility MRI, member of the national infrastructure France-BioImaging supported by the French National Research Agency (ANR-10-INBS-04, «Investments for the future»).

**Conflicts of Interest:** The authors declare no conflict of interest.

## References

1. David, A.R.; Zimmerman, M.R. Cancer: An old disease, a new disease or something in between? *Nat. Rev. Cancer* **2010**, *10*, 728–733. [CrossRef]

2. Schirrmacher, V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. *Int. J. Oncol.* **2019**, *54*, 407–419. [CrossRef]

3. Nussbaumer, S.; Bonnabry, P.; Veuthey, J.-L.; Fleury-Souverain, S. Analysis of anticancer drugs: A review. *Talanta* **2011**, *85*, 2265–2289. [CrossRef]

4. Huang, C.-Y.; Ju, D.-T.; Chang, C.-F.; Muralidhar Reddy, P.; Velmurugan, B.K. A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. *Biomed. Taipei 2017*, **7**, 23. [CrossRef]

5. Idris, N.M.; Gnanasammandhan, M.K.; Zhang, J.; Ho, P.C.; Mahendran, R.; Zhang, Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. *Nat. Med.* **2012**, *18*, 1580–1585. [CrossRef]
6. Henderson, B.W.; Dougherty, T.J. How does photodynamic therapy work? *Photochem. Photobiol.* **1992**, *55*, 145–157. [CrossRef]

7. Naik, A.; Rubbiani, R.; Gasser, G.; Spingler, B. Visible-Light-Induced Annihilation of Tumor Cells with Platinum-Porphyrin Conjugates. *Angew. Chem. Int. Ed.* **2014**, *53*, 6938–6941. [CrossRef]

8. Sanoj Rejinold, N.; Choi, G.; Choy, J.-H. Recent trends in nano photo-chemo therapy approaches and future scopes. *Coord. Chem. Rev.* **2020**, *411*, 213252. [CrossRef]

9. Cheng, Y.-J.; Hu, J.-J.; Qin, S.-Y.; Zhang, A.-Q.; Zhang, X.-Z. Recent advances in functional mesoporous silica-based nanoplatforms for combinational photo-chemotherapy of cancer. *Biomaterials* **2020**, *232*, 119738. [CrossRef]

10. Hu, C.; Zhuang, W.; Yu, T.; Chen, L.; Liang, Z.; Li, G.; Wang, Y. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy. *J. Mater. Chem. B* **2020**, *8*, 5267–5279. [CrossRef]

11. Hu, X.; Lu, Y.; Dong, C.; Zhao, W.; Wu, X.; Zhou, L.; Chen, L.; Yao, T.; Shi, S. A RuII Polypyridyl Alkyne Complex Based Metal–Organic Frameworks for Combined Photodynamic/Photothermal/Chemotherapy. *Chem. Eur. J.* **2020**, *26*, 1668–1675. [CrossRef]

12. Meng, L.-B.; Zhang, W.; Li, D.; Li, Y.; Hu, X.-Y.; Wang, L.; Li, G. pH-Responsive supramolecular vesicles assembled by water-soluble pillar [5] arene and a BODIPY photosensitizer for chemo-photodynamic dual therapy. *Chem. Commun.* **2015**, *51*, 14381–14384. [CrossRef]

13. Wang, D.; Wang, T.; Liu, J.; Yu, H.; Jiao, S.; Feng, B.; Zhou, F.; Fu, Y.; Yin, Q.; Zhang, P.; et al. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy. *Nano Lett.* **2016**, *16*, 5503–5513. [CrossRef]

14. Wang, X.; Liu, K.; Yang, G.; Cheng, L.; He, L.; Liu, Y.; Li, Y.; Guo, L.; Liu, Z. Near-infrared light triggered photodynamic therapy in combination with gene therapy using upconversion nanoparticles for effective cancer cell killing. *Nanoscale* **2014**, *6*, 9198–9205. [CrossRef]

15. Tseng, S.J.; Liao, Z.-X.; Kao, S.-H.; Zeng, Y.-F.; Huang, K.-Y.; Li, H.-J.; Yang, C.-L.; Deng, Y.-F.; Huang, C.-F.; Yang, S.-C.; et al. Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour. *Nat. Commun.* **2015**, *6*, 6456. [CrossRef]

16. Sun, S.; Xu, Y.; Fu, P.; Chen, M.; Sun, S.; Zhao, R.; Wang, J.; Liang, X.; Wang, S. Ultrasound-targeted photodynamic and gene dual therapy for effectively inhibiting triple negative breast cancer by cationic porphyrin lipid microbubbles loaded with HIF1α-siRNA. *Nanoscale* **2018**, *10*, 19945–19956. [CrossRef]

17. Chen, W.-H.; Lecaros, R.L.G.; Tseng, Y.-C.; Huang, L.; Hsu, Y.-C. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. *Cancer Lett.* **2015**, *359*, 65–74. [CrossRef]

18. Zhao, R.; Liang, X.; Zhao, B.; Chen, M.; Liu, R.; Sun, S.; Yue, X.; Wang, S. Ultrasound assisted gene and photodynamic synergistic therapy with multifunctional FOXA1-siRNA loaded porphyrin microbubbles for enhancing therapeutic efficacy for breast cancer. *Biomaterials* **2018**, *173*, 58–70. [CrossRef]

19. Huang, C.; Zheng, J.; Ma, D.; Liu, N.; Zhu, C.; Li, J.; Yang, R. Hypoxia-triggered gene therapy: A new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapy. *J. Mater. Chem. B* **2018**, *6*, 6424–6430. [CrossRef]

20. Laroui, N.; Coste, M.; Lichon, L.; Bessin, Y.; Gary-Bobo, M.; Pratviel, G.; Bonduelle, C.; Bettache, N.; Ulrich, S. Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes. *Int. J. Pharm.* **2019**, *569*, 118585. [CrossRef]

21. Mauriello Jimenez, C.; Aggad, D.; Croissant, J.G.; Tresfield, K.; Laurencin, D.; Berthomieu, D.; Cubedo, N.; Rossel, M.; Alsaiari, S.; Anjum, D.H.; et al. Porous Porphyrin-Based Organosilica Nanoparticles for NIR Two-Photon Photodynamic Therapy and Gene Delivery in Zebrafish. *Adv. Funct. Mater.* **2018**, *28*, 1800235. [CrossRef]

22. Vankayala, R.; Kuo, C.-L.; Nuthalapati, K.; Chiang, C.-S.; Hwang, K.C. Nucleus-Targeting Gold Nanoclusters for Simultaneous In Vivo Fluorescence Imaging, Gene Delivery, and NIR-Light Activated Photodynamic Therapy. *Adv. Funct. Mater.* **2015**, *25*, 5934–5945. [CrossRef]

23. Vijayaraghavan, P.; Vankayala, R.; Chiang, C.-S.; Sung, H.-W.; Hwang, K.C. Complete destruction of deep-tissue buried tumors via combination of gene silencing and gold nanoechinus-mediated photodynamic therapy. *Biomaterials* **2015**, *62*, 13–23. [CrossRef]
24. Schumann, C.; Taratula, O.; Khalimonchuk, O.; Palmer, A.L.; Cronk, L.M.; Jones, C.V.; Escalante, C.A.; Taratula, O. ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression. *Nanomed. Nanotechnol. Biol. Med.* **2015**, *11*, 1961–1970. [CrossRef]

25. Liang, R.; Tian, R.; Ma, L.; Zhang, L.; Hu, Y.; Wang, J.; Wei, M.; Yan, D.; Evans, D.G.; Duan, X. A Supermolecular Photosensitizer with Excellent Anticancer Performance in Photodynamic Therapy. *Adv. Funct. Mater.* **2014**, *24*, 3144–3151. [CrossRef]

26. Chen, H.; Xiao, L.; Anraku, Y.; Mi, P.; Liu, X.; Cabral, H.; Inoue, A.; Nomoto, T.; Kishimura, A.; Nishiyama, N.; et al. Polyion Complex Vesicles for Photoinduced Intracellular Delivery of Amphiphilic Photosensitizer. *J. Am. Chem. Soc.* **2014**, *136*, 157–163. [CrossRef]

27. Jiang, H.; Taranekar, P.; Reynolds, J.R.; Schanze, K.S. Conjugated Polyelectrolytes: Synthesis, Photophysics, and Applications. *Angew. Chem. Int. Ed.* **2009**, *48*, 4300–4316. [CrossRef]

28. Feng, X.; Liu, L.; Wang, S.; Zhu, D. Water-soluble fluorescent conjugated polymers and their interactions with biomacromolecules for sensitive biosensors. *Chem. Soc. Rev.* **2010**, *39*, 2411–2419. [CrossRef] [PubMed]

29. Jeong, J.E.; Woo, H.Y. Control of electrostatic interaction between a molecular beacon aptamer and conjugated polyelectrolyte for detection range-tunable ATP assay. *Polym. Chem.* **2017**, *8*, 6329–6334. [CrossRef]

30. Xia, F.; Zuo, X.; Yang, R.; Xiao, Y.; Kang, D.; Vallée-Bélisle, A.; Gong, X.; Heeger, A.J.; Plaxco, K.W. On the Binding of Cationic, Water-Soluble Conjugated Polymers to DNA: Electrostatic and Hydrophobic Interactions. *J. Am. Chem. Soc.* **2010**, *132*, 1252–1254. [CrossRef]

31. Rubio-Magnieto, J.; Thomas, A.; Richeter, S.; Mehdi, A.; Dubois, P.; Lazzaroni, R.; Clement, S.; Surin, M. Chirality in DNA-[small pi]-conjugated polymer supramolecular structures: Insights into the self-assembly. *Chem. Commun.* **2013**, *49*, 5483–5485. [CrossRef]

32. Rubio-Magnieto, J.; Azene, E.G.; Knoops, J.; Knippenberg, S.; Delcourt, C.; Thomas, A.; Richeter, S.; Mehdi, A.; Dubois, P.; Lazzaroni, R.; et al. Self-assembly and hybridization mechanisms of DNA with cationic polythiophene. *Soft Matter* **2015**, *11*, 6460–6471. [CrossRef]

33. Leclercq, M.; Rubio-Magnieto, J.; Mohammed, D.; Gabriele, S.; Leclercq, L.; Cottet, H.; Richeter, S.; Clément, S.; Surin, M. Supramolecular Self-Assembly of DNA with a Cationic Polythiophene: From Polyplexes to Fibers. *ChemNanoMat* **2019**, *5*, 703–709. [CrossRef]

34. Liang, J.; Li, K.; Liu, B. Visual sensing with conjugated polyelectrolytes. *Chem. Sci.* **2013**, *4*, 1377–1394. [CrossRef]

35. Feng, G.; Ding, D.; Liu, B. Fluorescence bioimaging with conjugated polyelectrolytes. *Nanoscale* **2012**, *4*, 6150–6165. [CrossRef] [PubMed]

36. Wu, W.; Bazan, G.C.; Liu, B. Conjugated-Polymer-Amplified Sensing, Imaging, and Therapy. *Chem* **2017**, *2*, 760–790. [CrossRef]

37. Zhan, R.; Liu, B. Functionalized Conjugated Polyelectrolytes for Biological Sensing and Imaging. *Chem. Rec.* **2016**, *16*, 1715–1740. [CrossRef] [PubMed]

38. Feng, X.; Lv, F.; Liu, L.; Yang, Q.; Wang, S.; Bazan, G.C. A Highly Emissive Conjugated Polyelectrolyte Vector for Gene Delivery and Transfection. *Adv. Mater.* **2012**, *24*, 5428–5432. [CrossRef]

39. Wang, G.; Yin, H.; Yin, Ng, J.C.; Cai, L.; Li, J.; Tang, B.Z.; Liu, B. Polyethyleneimine-grafted hyperbranched conjugated polyelectrolytes: Synthesis and imaging of gene delivery. *Polym. Chem.* **2013**, *4*, 5297–5304. [CrossRef]

40. Li, S.; Yuan, H.; Chen, H.; Wang, X.; Zhang, P.; Lv, F.; Liu, L.; Wang, S. Cationic Poly (p-phenylene vinylene) Materials as a Multifunctional Platform for Light-Enhanced siRNA Delivery. *Chem. Asian J.* **2016**, *11*, 2686–2689. [CrossRef]

41. Jiang, R.; Lu, X.; Yang, M.; Deng, W.; Fan, Q.; Huang, W. Monodispersed Brush-Like Conjugated Polyelectrolyte Nanoparticles with Efficient and Visualized SiRNA Delivery for Gene Silencing. *Biomacromolecules* **2013**, *14*, 3643–3652. [CrossRef] [PubMed]

42. Zhao, H.; Tao, H.; Hu, W.; Miao, X.; Tang, Y.; He, T.; Li, J.; Wang, Q.; Guo, L.; Lu, X.; et al. Two-Photon-Induced Charge-Variable Conjugated Polyelectrolyte Brushes for Effective Gene Silencing. *ACS Appl. Bio Mater.* **2019**, *2*, 1676–1685. [CrossRef]

43. Zhang, Y.; Li, X.; Wu, T.; Sun, J.; Wang, X.; Cao, L.; Feng, F. Cationic Polythiophenes as Gene Delivery Enhancer. *ACS Appl. Mater. Interfaces* **2017**, *9*, 16735–16740. [CrossRef]
44. Zhang, C.; Ji, J.; Shi, X.; Zheng, X.; Wang, X.; Feng, F. Synthesis of Structurally Defined Cationic Polythiophenes for DNA Binding and Gene Delivery. *ACS Appl. Mater. Interfaces* **2018**, *10*, 4519–4529. [CrossRef] [PubMed]

45. Zhao, H.; Hu, W.; Ma, H.; Jiang, R.; Tang, Y.; Ji, Y.; Lu, X.; Hou, B.; Deng, W.; Huang, W.; et al. Photo-Induced Charge-Variable Conjugated Polyelectrolyte Brushes Encapsulating Upconversion Nanoparticles for Promoted siRNA Release and Collaborative Photodynamic Therapy under NIR Light Irradiation. *Adv. Funct. Mater.* **2017**, *27*, 1702592. [CrossRef]

46. Hu, R.; Li, S.-L.; Bai, H.-T.; Wang, Y.-X.; Liu, L.-B.; Lv, F.-T.; Wang, S. Regulation of oxidative stress inside living cells through polythiophene derivatives. *Chin. Chem. Lett.* **2016**, *27*, 545–549. [CrossRef]

47. So, R.C.; Carreon-Asok, A.C. Molecular Design, Synthetic Strategies, and Applications of Cationic Polythiophenes. *Chem. Rev.* **2019**, *119*, 11442–11509. [CrossRef]

48. Lan, M.; Zhao, S.; Xie, Y.; Zhao, J.; Guo, L.; Niu, G.; Li, Y.; Sun, H.; Zhang, H.; Liu, W.; et al. Water-Soluble Polythiophene for Two-Photon Excitation Fluorescence Imaging and Photodynamic Therapy of Cancer. *ACS Appl. Mater. Interfaces* **2017**, *9*, 14590–14595. [CrossRef]

49. Guo, L.; Ge, J.; Liu, Q.; Jia, Q.; Zhang, H.; Liu, W.; Niu, G.; Liu, S.; Gong, J.; Hackbarth, S.; et al. Versatile Polymer Nanoparticles as Two-Photon-Triggered Photosensitizers for Simultaneous Cellular, Deep-Tissue Imaging, and Photodynamic Therapy. *Adv. Healthc. Mater.* **2017**, *6*, 1601431. [CrossRef]

50. Osaka, I.; McCullough, R.D. Advances in Molecular Design and Synthesis of Regioregular Polythiophenes. *Acc. Chem. Res.* **2008**, *41*, 1202–1214. [CrossRef]

51. Amna, B.; Siddiqi, H.M.; Hassan, A.; Ozturk, T. Recent developments in the synthesis of regioregular thiophene-based conjugated polymers for electronic and optoelectronic applications using nickel and palladium-based catalytic systems. *RSC Adv.* **2020**, *10*, 4322–4396. [CrossRef]

52. Layman, J.M.; Ramirez, S.M.; Green, M.D.; Long, T.E. Influence of Polycation Molecular Weight on Poly (2-dimethylaminoethyl methacrylate)-Mediated DNA Delivery In Vitro. *Biomacromolecules* **2009**, *10*, 1244–1252. [CrossRef] [PubMed]

53. Alameh, M.; Lavertu, M.; Tran-Khanh, N.; Chang, C.-Y.; Lesage, F.; Bail, M.; Darras, V.; Chevrier, A.; Buschmann, M.D. siRNA Delivery with Chitosan: Influence of Chitosan Molecular Weight, Degree of Deacetylation, and Amine to Phosphate Ratio on in Vitro Silencing Efficiency, Hemocompatibility, Biodistribution, and in Vivo Efficacy. *Biomacromolecules* **2018**, *19*, 112–131. [CrossRef] [PubMed]

54. Morimoto, K.; Nishikawa, M.; Kawakami, S.; Nakano, T.; Hattori, Y.; Fumoto, S.; Yamashita, F.; Hashida, M. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. *Mol. Ther.* **2003**, *7*, 254–261. [CrossRef]

55. Loczenski Rose, V.; Mastrotto, F.; Mantovani, G. Phosphonium polymers for gene delivery. *Polym. Chem.* **2017**, *8*, 353–360. [CrossRef]

56. Ornelas-Megiatto, C.; Wich, P.R.; Fréchet, J.M.J. Polyphosphonium Polymers for siRNA Delivery: An Efficient and Nontoxic Alternative to Polyammonium Carriers. *J. Am. Chem. Soc.* **2012**, *134*, 1902–1905. [CrossRef]

57. Hemp, S.T.; Allen, M.H.; Green, M.D.; Long, T.E. Phosphonium-Containing Polyelectrolytes for Nonviral Gene Delivery. *Biomacromolecules* **2012**, *13*, 231–238. [CrossRef]

58. Clement, S.; Tizit, A.; Desbief, S.; Mehdi, A.; De Winter, J.; Gerbaux, P.; Lazzaroni, R.; Boury, B. Synthesis and characterisation of [small pi]-conjugated polymer/silica hybrids containing regioregular ionic polythiophenes. *J. Mater. Chem.* **2011**, *21*, 2733–2739. [CrossRef]

59. Gary-Bobo, M.; Mir, Y.; Rouxel, C.; Brevet, D.; Basile, I.; Maynadier, M.; Vaillant, O.; Mongin, O.; Blanchard-Desce, M.; Morère, A.; et al. Mannose-Functionalized Mesoporous Silica Nanoparticles for Efficient Two-Photon Photodynamic Therapy of Solid Tumors. *Angew. Chem. Int. Ed.* **2011**, *50*, 11425–11429. [CrossRef]

60. Marrocchi, A.; Lanari, D.; Facchetti, A.; Vaccaro, L. Poly (3-hexylthiophene): Synthetic methodologies and properties in bulk heterojunction solar cells. *Energy Environ. Sci.* **2012**, *5*, 8457–8474. [CrossRef]

61. Brouwer, A. Standards for photoluminescence quantum yield measurements in solution (IUPAC Technical Report) *. *Pure Appl. Chem.* **2011**, *83*, 2213–2228. [CrossRef]

62. Zhang, X.; Rodgers, M.A.J. Energy and Electron Transfer Reactions of the MLCT State of Ruthenium Tris (bipyridyl) with Molecular Oxygen: A Laser Flash Photolysis Study. *J. Phys. Chem.* **1995**, *99*, 12797–12803. [CrossRef]
63. Trznadel, M.; Pron, A.; Zagorska, M.; Chrzaszcz, R.; Pielichowski, J. Effect of Molecular Weight on Spectroscopic and Spectroelectrochemical Properties of Regioregular Poly (3-hexylthiophene). *Macromolecules* **1998**, *31*, 5051–5058. [CrossRef] [PubMed]

64. Gaylord, B.S.; Heeger, A.J.; Bazan, G.C. DNA Hybridization Detection with Water-Soluble Conjugated Polymers and Chromophore-Labeled Single-Stranded DNA. *J. Am. Chem. Soc.* **2003**, *125*, 896–900. [CrossRef] [PubMed]

65. Tan, C.; Pinto, M.R.; Schanze, K.S. Photophysics, aggregation and amplified quenching of a water-soluble poly (phenylene ethynylene). *Chem. Commun.* **2002**, 446–447. [CrossRef]

66. Zhao, X.; Pinto, M.R.; Hardison, L.M.; Mwaura, J.; Müller, J.; Jiang, H.; Witker, D.; Kleiman, V.D.; Reynolds, J.R.; Schanze, K.S. Variable Band Gap Poly (arylene ethynylene) Conjugated Polyelectrolytes. *Macromolecules* **2006**, *39*, 6355–6366. [CrossRef]

67. Cook, S.; Furube, A.; Katoh, R. Analysis of the excited states of regioregular polythiophene P3HT. *Energy Environ. Sci.* **2008**, *1*, 294–299. [CrossRef]

68. Kraabel, B.; Moses, D.; Heeger, A.J. Direct observation of the intersystem crossing in poly (3-octylthiophene). *J. Chem. Phys.* **1995**, *103*, 5102–5108. [CrossRef]

69. Khatoon, S.S.; Chen, Y.; Zhao, H.; Lv, F.; Liu, L.; Wang, S. In situ self-assembly of conjugated polyelectrolytes for cancer targeted imaging and photodynamic therapy. *Biomater. Sci.* **2020**, *8*, 2156–2163. [CrossRef]

70. Lovell, J.F.; Liu, T.W.B.; Chen, J.; Zheng, G. Activatable Photosensitizers for Imaging and Therapy. *Chem. Rev.* **2010**, *110*, 2839–2857. [CrossRef]

71. Fernández, D.A.; Awruch, J.; Dicelio, L.E. Photophysical and Aggregation Studies of t-Butyl-Substituted Zn Phthalocyanines. *Photochem. Photobiol.* **1996**, *63*, 784–792. [CrossRef]

72. Zhang, C.; Du, K.; Zhang, X.; Zheng, X.; Cao, G.; Zhang, F.; Feng, F. Optical properties of phosphonium-, quaternary ammonium- and imidazolium- substituted regioregular polythiophenes and application for imaging live cells. *Dye. Pigm.* **2019**, *170*, 107581. [CrossRef]

73. Zhao, J.; Stenzel, M.H. Entry of nanoparticles into cells: The importance of nanoparticle properties. *Polym. Chem.* **2018**, *9*, 259–272. [CrossRef]

74. Zhang, S.; Gao, H.; Bao, G. Physical Principles of Nanoparticle Cellular Endocytosis. *ACS Nano* **2015**, *9*, 8655–8671. [CrossRef] [PubMed]

75. Yue, Z.-G.; Wei, W.; Lv, P.-P.; Yue, H.; Wang, L.-Y.; Su, Z.-G.; Ma, G.-H. Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles. *Biomacromolecules* **2011**, *12*, 2440–2446. [CrossRef] [PubMed]

<figure><img src="image_9.png" /></figure>

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).